Pharmacovigilance study and development of a clinical decision flowchart for personalized selection of trastuzumab, T-DXd, and T-DM1 in breast cancer patients
Fields of Study & Subjects
HER2/EGFR in Cancer Research
Advanced Breast Cancer Therapies
Pharmacovigilance and Adverse Drug Reactions
Publication details
- Journal / source
- Clinical & Translational Oncology
- Publisher
- Springer Science and Business Media LLC
- Volume
- 28
- Issue
- 6
- Pages
- 2118–2134
- Publication date
- 10 January 2026
- Language
- EN